Pharmacokinetics of Micafungin (Mycamin) as Antifungal Prophylaxis Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease.

Trial Profile

Pharmacokinetics of Micafungin (Mycamin) as Antifungal Prophylaxis Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jul 2017

At a glance

  • Drugs Micafungin (Primary)
  • Indications Aspergillosis
  • Focus Pharmacokinetics
  • Acronyms MATADOR
  • Most Recent Events

    • 15 Sep 2016 Status changed from recruiting to completed.
    • 29 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
    • 30 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top